Time in therapeutic range and risk of thromboembolism and bleeding in patients with a mechanical heart valve prosthesis-Reference-Cited by-同舟云学术

Time in therapeutic range and risk of thromboembolism and bleeding in patients with a mechanical heart valve prosthesis

Published:2020-01 Issue:1 Volume:159 Page:74-83.e4
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Havers-Borgersen Eva,Butt Jawad H.,Vinding Naja E.,Torp-Pedersen Christian,Gislason Gunnar,Køber Lars,Fosbøl Emil L.

Funder

Danish Council for Independent Research

Bayer

Biotronic

Bristol-Myers Squibb

Pfizer

AstraZeneca

Boehringer Ingelheim

Janssen and Janssen

Bristol-Myers

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference26 articles.

1. Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends;Sun;Lancet,2009

2. Guidelines on the management of valvular heart disease (version 2012) the joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS);Eur Heart J,2017

3. Antitrombotisk behandling ved kardiovaskulære sygdomme “Trombokardiologi”.;Husted;DCS vejledning,2012

4. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS;Kirchhof;Rev Esp Cardiol (Engl Ed),2017

5. Outcomes in a warfarin-treated population with atrial fibrillation;Björck;JAMA Cardiol,2016

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of time in therapeutic range on postoperative complications in mechanical heart valve replacement patients operated with the indigenous TTK Chitra heart valve;Heart, Vessels and Transplantation;2024-04-28

2. Oral Anticoagulation Use in Individuals With Atrial Fibrillation and Chronic Kidney Disease: A Review;Seminars in Nephrology;2024-03

3. Thirty-year outcomes of low-intensity anticoagulation for mechanical aortic valve;Heart and Vessels;2024-02-23

4. Outcomes of Patients with a Mechanical Heart Valve and Poor Anticoagulation Control on Warfarin;Thrombosis and Haemostasis;2023-12-29

5. DOES THE TIMING OF WARFARIN INGESTION AFFECT THE TIME IN THERAPEUTIC RANGE IN PATIENTS WITH METALLIC PROSTHETIC VALVE?;Journal of Contemporary Medicine;2023-07-31